CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Pharma Industry to Thrive Exponentially in the Future Years

Pharma Industry to Thrive...

Top Upcoming Trends In Pharma Industry

Top Upcoming Trends In Pharma Industry

Arisglobal's Lifesphere Safety Bolsters Market Leading Position In Pharmacovigilance

Arisglobal's Lifesphere Safety...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Dynamic Commercial Aspects  of Life Sciences

Dynamic Commercial Aspects of Life...

Pharma Industry to Thrive Exponentially in the Future Years

Pharma Industry to Thrive...

Top Upcoming Trends In Pharma Industry

Top Upcoming Trends In Pharma Industry

Arisglobal's Lifesphere Safety Bolsters Market Leading Position In Pharmacovigilance

Arisglobal's Lifesphere Safety...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Dynamic Commercial Aspects  of Life Sciences

Dynamic Commercial Aspects of Life...

French Pharmaceutical Company Rigorously Audits Multiple Digital Validation Solutions Selects ValGenesis VLMS

Life Sciences Review Life Sciences Review | Thursday, March 03, 2022
Tweet

Fremont, CA: A French pharmaceutical company chose ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system – to digitalize its corporate validation process.


ValGenesis expanded its footprint in France following months of rigorous QA audits and selection processes. The company, which specializes in neuroscience and rare diseases and sells its products in over 100 countries, used sophisticated evaluation criteria to match vendor capabilities with their stringent business requirements. ValGenesis VLMS emerged as the clear winner at the end of the process.


ValGenesis VLMS, which is delivered as a service, impressed the customer with its remote validation and efficient change and risk management capabilities, which enable new levels of collaboration and improve enterprise-wide visibility into the validation process.


Check Out : Business Management Review


Change control-driven validation activities are decreased from weeks to hours with ValGenesis VLMS, and the company gains faster access to detailed metrics that help lower costs and cycle time.


"France ranks fourth in pharmaceutical production within the EU, making this a very exciting time for us to work with the country's most trusted pharmaceutical company," remarks Narayan Raj, Chief Operating Officer at ValGenesis. "Our SaaS-based solution was rigorously tested and earned their trust to create fully automated and transparent corporate validation processes that are standardized, optimized and audit-ready. This frees them to do what they do best: developing breakthrough treatments for patients around the globe. We look forward to an exciting journey ahead with them," he concluded.


Weekly Brief

loading
TOP VENDORS
Top 10 Emerging Pharma Consulting Companies – 2022
TOP VENDORS
Top 10 Pharma Consulting Companies – 2022
TOP VENDORS
Top 10 Emerging Pharma Consulting Companies – 2022
TOP VENDORS
Top 10 Pharma Consulting Companies – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Atavistik Bio Enhances Atavistic's AMPS Platform through Collaboration with Plex Research

Managing Data in Digital Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/french-pharmaceutical-company-rigorously-audits-multiple-digital-validation-solutions-selects-valgenesis-vlms-nwid-735.html